Retroperitoneal sarcomas.

Current treatment options in oncology

Volumn 1, Issue 3, 2000, Pages 274-278

  Eilber, Fritz C ^a   Eilber, Karyn S ^b   Eilber, Frederick R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BIOPSY; CLINICAL TRIAL; HUMAN; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY; RETROPERITONEAL TUMOR; REVIEW; SARCOMA; SURVIVAL RATE; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; BIOPSY; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; RETROPERITONEAL NEOPLASMS; SARCOMA; SURVIVAL RATE;

EID: 0034256289     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-000-0040-y     Document Type: Review

References (21)

1. 1. FK Storm DM Mahvi 1991 Diagnosis and management of retroperitoneal soft-tissue sarcoma Ann Surg 214 2 10 2064467 10.1097/00000658-199107000-00002 1:STN:280:By6B1M%2FptlE%3D Storm FK, Mahvi DM: Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg 1991, 214:2–10.
2. 2. S Singer TJ Eberlein 1997 Surgical management of softtissue sarcoma Adv Surg 31 395 420 9408503 1:STN:280:DyaK1c%2Fnt1OrsQ%3D%3D Singer S, Eberlein TJ: Surgical management of softtissue sarcoma. Adv Surg 1997, 31:395–420.
3. 3. W Sindelar T Kinsella P Chen 1993 Intraoperative radiotherapy I retroperitoneal sarcoma: final results of a prospective randomized clinical trial Arch Surg 128 402 410 8457152 1:STN:280:ByyB3cjkt1M%3D Sindelar W, Kinsella T, Chen P, et al.: Intraoperative radiotherapy I retroperitoneal sarcoma: final results of a prospective randomized clinical trial. Arch Surg 1993, 128:402–410.
4. 4. M Arlen RC Marcove 1987 Retroperitoneal sarcomas Surgical Management of Soft Tissue Sarcomas WB Saunders Philadelphia 220 220 Arlen M, Marcove RC: Retroperitoneal sarcomas. In Surgical Management of Soft Tissue Sarcomas. Philadelphia: WB Saunders; 1987:220.
5. 5. MJ Heslin JJ Lewis E Nadler 1997 Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management J Clin Oncol 15 2832 2839 9256126 1:STN:280:ByiA1MfitVU%3D Heslin MJ, Lewis JJ, Nadler E, et al.: Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997, 15:2832–2839.
6. 6. JJ Lewis D Leung JM Woodruff MF Brennan 1998 Retroperitoneal soft-tissue sarcoma Ann Surg 228 355 365 9742918 10.1097/00000658-199809000-00008 1:STN:280:DyaK1cvhtlymsg%3D%3D Largest series of retroperitoneal sarcomas. Excellent analysis of prognostic factors Lewis JJ, Leung D, Woodruff JM, Brennan MF: Retroperitoneal soft-tissue sarcoma. Ann Surg 1998, 228:355–365. Largest series of retroperitoneal sarcomas. Excellent analysis of prognostic factors.
7. 7. RG Bevilacqua A Rogatko SI Hajdu MF Brennan 1991 Prognostic factors in primary retroperitoneal softtissue sarcomas Arch Surg 126 328 334 1998475 1:STN:280:By6C2M7is10%3D Bevilacqua RG, Rogatko A, Hajdu SI, Brennan MF: Prognostic factors in primary retroperitoneal softtissue sarcomas. Arch Surg 1991, 126:328–334.
8. 8. S Singer JM Corson GD Demetri 1995 Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma Ann Surg 221 185 195 7857146 10.1097/00000658-199502000-00009 1:STN:280:ByqC28%2FlsV0%3D Singer S, Corson JM, Demetri GD, et al.: Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995, 221:185–195.
9. 9. JW Kilkenny KI Bland EM Copeland 1996 Retroperitoneal sarcoma: the University of Florida experience J Am Coll Surg 182 329 339 8605556 Kilkenny JW, Bland KI, Copeland EM: Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg 1996, 182:329–339.
10. 10. JC Alvarenga AB Ball C Fisher 1991 Limitations of surgery in the treatment of retroperitoneal sarcoma Br J Surg 78 912 916 1913104 10.1002/bjs.1800780806 1:STN:280:By2D3cvmsFU%3D Alvarenga JC, Ball AB, Fisher C, et al.: Limitations of surgery in the treatment of retroperitoneal sarcoma. Br J Surg 1991, 78:912–916.
11. 11. G Rosen C Forscher S Lowenbraun F Eilber 1994 Synovial sarcoma. Uniform response of metastases to high dose ifosfamide Cancer 73 2506 2511 8174046 10.1002/1097-0142(19940515)73:10<2506::AID-CNCR2820731009>3.0.CO;2-S 1:STN:280:ByuB38fktlc%3D Rosen G, Forscher C, Lowenbraun S, Eilber F, et al.: Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer 1994, 73:2506–2511.
12. 12. A Cesne Le E Antoine M Spielmann 1995 High-dose ifosfamide: circumvention of resistance to standarddose ifosfamide in advanced soft tissue sarcomas J Clin Oncol 13 1600 1608 7541449 Le Cesne A, Antoine E, Spielmann M, et al.: High-dose ifosfamide: circumvention of resistance to standarddose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol 1995, 13:1600–1608.
13. 13. FR Eilber J Eckardt 1997 Surgical management of soft tissue sarcomas Semin Oncol 24 526 533 9344318 1:STN:280:DyaK1c%2FgtlSjsQ%3D%3D Eilber FR, Eckardt J: Surgical management of soft tissue sarcomas. Semin Oncol 1997, 24:526–533.
14. 14. Haskell CM. Cancer Treatment, edn 4. WB Saunders; 1995:108-110, 123-125.
15. 15. RM O’Bryan LH Baker JE Gottlieb 1977 Dose response evaluation of adriamycin in human neoplasia Cancer 39 1940 1948 858124 10.1002/1097-0142(197705)39:5<1940::AID-CNCR2820390505>3.0.CO;2-0 1:STN:280:CSiC2MbotVc%3D O’Bryan RM, Baker LH, Gottlieb JE, et al.: Dose response evaluation of adriamycin in human neoplasia. Cancer 1977, 39:1940–1948.
16. 16. SS Legha RS Benjamin B Mackay 1982 Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion Ann Intern Med 96 133 139 7059060 1:STN:280:Bi2C3szjsVA%3D Legha SS, Benjamin RS, Mackay B, et al.: Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 1982, 96:133–139.
17. 17. AD Elias JP Eder T Shea 1990 High-dose ifosfamide with mesna uroprotection: a phase I study J Clin Oncol 8 170 178 2104923 1:STN:280:By%2BC3M7nvVE%3D Elias AD, Eder JP, Shea T, et al.: High-dose ifosfamide with mesna uroprotection: a phase I study. J Clin Oncol 1990, 8:170–178.
18. 18. CN Catton B O’Sullivan C Kotwall 1994 Outcome and prognosis in retroperitoneal soft tissue sarcoma Int J Radiat Oncol Biol Phys 29 1005 1010 8083069 1:STN:280:ByuA28vot1M%3D Catton CN, O’Sullivan B, Kotwall C, et al.: Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1994, 29:1005–1010.
19. 19. JA Clark JE Tepper 1996 Role of radiation therapy in retroperitoneal sarcomas Oncology 10 1867 1874 8985970 1:STN:280:ByiC3sfpvFw%3D Clark JA, Tepper JE: Role of radiation therapy in retroperitoneal sarcomas. Oncology 1996, 10:1867–1874.
20. 20. OJ Hines S Nelson WJ Quinones-Baldrich FR Eilber 1999 Leiomyosarcoma of the inferior vena cava. Prognosis and comparison with leiomyosarcoma of other anatomic sites Cancer 85 1077 1083 10091791 10.1002/(SICI)1097-0142(19990301)85:5<1077::AID-CNCR10>3.0.CO;2-0 1:STN:280:DyaK1M7ptVaisA%3D%3D This is an important study of the unique biology of a rare retroperitoneal sarcoma Hines OJ, Nelson S, Quinones-Baldrich WJ, Eilber FR: Leiomyosarcoma of the inferior vena cava. Prognosis and comparison with leiomyosarcoma of other anatomic sites. Cancer 1999, 85:1077–1083. This is an important study of the unique biology of a rare retroperitoneal sarcoma.
21. 21. K Herman T Kusy 1998 Retroperitoneal sarcoma-the continued challenge for surgery and oncology Surg Oncol 7 77 81 10421510 10.1016/S0960-7404(99)00002-X 1:STN:280:DyaK1Mzkslykug%3D%3D Herman K, Kusy T: Retroperitoneal sarcoma-the continued challenge for surgery and oncology. Surg Oncol 1998, 7:77–81.